RAAS TRIPLE-A

Serial Number 79256903
Registration 5993170
700

Registration Progress

Application Filed
Dec 19, 2018
Under Examination
Approved for Publication
Dec 10, 2019
Published for Opposition
Dec 10, 2019
Registered
Feb 25, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-25)
Due: Feb 25, 2026 227 days

Trademark Image

RAAS TRIPLE-A

Basic Information

Serial Number
79256903
Registration Number
5993170
Filing Date
December 19, 2018
Registration Date
February 25, 2020
Published for Opposition
December 10, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 25, 2020
Registration
Registered
Classes
001 005 009 042
+1 more

Rights Holder

ATTOQUANT DIAGNOSTICS GMBH

16
Address
Campus-Vienna-Biocenter 5
A-1030 Wien
AT

Ownership History

ATTOQUANT DIAGNOSTICS GMBH

Original Applicant
16
AT

ATTOQUANT DIAGNOSTICS GMBH

Owner at Publication
16
AT

ATTOQUANT DIAGNOSTICS GMBH

Original Registrant
16
AT

Legal Representation

Attorney
Frank Terranella

USPTO Deadlines

Next Deadline
227 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-25)
Due Date
February 25, 2026
Grace Period Ends
August 25, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description
Feb 25, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 4, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Nov 26, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Jul 17, 2020 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 25, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jun 25, 2020 FIMP P FINAL DISPOSITION PROCESSED
May 25, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 25, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2019 PUBO A PUBLISHED FOR OPPOSITION
Nov 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED
Nov 3, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 3, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED
Nov 3, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 17, 2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 17, 2019 GNFR O FINAL REFUSAL E-MAILED
Sep 17, 2019 CNFR R FINAL REFUSAL WRITTEN
Aug 14, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2019 ALIE A ASSIGNED TO LIE
Aug 5, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2019 RFNT P REFUSAL PROCESSED BY IB
May 22, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2019 RFRR P REFUSAL PROCESSED BY MPU
Apr 30, 2019 MAFR O APPLICATION FILING RECEIPT MAILED
Apr 26, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 25, 2019 CNRT R NON-FINAL ACTION WRITTEN
Apr 24, 2019 DOCK D ASSIGNED TO EXAMINER
Apr 24, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 001
Chemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system
Class 005
Diagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Class 009
Downloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Class 042
Medical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Class 044
Medical services, medical care, medical testing in the nature of medical diagnostic testing; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 009 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RAAS"

USPTO Documents

Loading USPTO documents...